The University of Southampton
University of Southampton Institutional Repository

Probiotics for Antibiotic-Associated Diarrhoea (PAAD): a prospective observational study of antibiotic-associated diarrhoea (including Clostridium difficile-associated diarrhoea) in care homes

Probiotics for Antibiotic-Associated Diarrhoea (PAAD): a prospective observational study of antibiotic-associated diarrhoea (including Clostridium difficile-associated diarrhoea) in care homes
Probiotics for Antibiotic-Associated Diarrhoea (PAAD): a prospective observational study of antibiotic-associated diarrhoea (including Clostridium difficile-associated diarrhoea) in care homes

BACKGROUND: Antibiotic prescribing rates in care homes are higher than in the general population. Antibiotics disrupt the normal gut flora, sometimes causing antibiotic-associated diarrhoea (AAD). Clostridium difficile (Hall and O'Toole 1935) Prévot 1938 is the most commonly identified cause of AAD. Little is known either about the frequency or type of antibiotics prescribed in care homes or about the incidence and aetiology of AAD in this setting.

OBJECTIVES: The Probiotics for Antibiotic-Associated Diarrhoea (PAAD) study was designed as a two-stage study. PAAD stage 1 aimed to (1) prospectively describe antibiotic prescribing in care homes; (2) determine the incidence of C. difficile carriage and AAD (including C. difficile-associated diarrhoea); and (3) to consider implementation challenges and establish the basis for a sample size estimation for a randomised controlled trial (RCT) of probiotic administration with antibiotics to prevent AAD in care homes. If justified by PAAD stage 1, the RCT would be implemented in PAAD stage 2. However, as a result of new evidence regarding the clinical effectiveness of probiotics on the incidence of AAD, a decision was taken not to proceed with PAAD stage 2.

DESIGN: PAAD stage 1 was a prospective observational cohort study in care homes in South Wales with up to 12 months' follow-up for each resident.

SETTING: Recruited care homes had management and owner's agreement to participate and three or more staff willing to take responsibility for implementing the study.

PARTICIPANTS: Eleven care homes were recruited, but one withdrew before any residents were recruited. A total of 279 care home residents were recruited to the observational study and 19 withdrew, 16 (84%) because of moving to a non-participating care home.

MAIN OUTCOME MEASURES: The primary outcomes were the rate of antibiotic prescribing, incidence of AAD, defined as three or more loose stools (type 5-7 on the Bristol Stool Chart) in a 24-hour period, and C. difficile carriage confirmed on stool culture.

RESULTS: Stool samples were obtained at study entry from 81% of participating residents. Over half of the samples contained antibiotic-resistant isolates, with Enterobacteriaceae resistant to ciprofloxacin in 47%. Residents were prescribed an average of 2.16 antibiotic prescriptions per year [95% confidence interval (CI) 1.90 to 2.46]. Antibiotics were less likely to be prescribed to residents from dual-registered homes. The incidence of AAD was 0.57 (95% CI 0.41 to 0.81) episodes per year among those residents who were prescribed antibiotics. AAD was more likely in residents who were prescribed co-amoxiclav than other antibiotics and in those residents who routinely used incontinence pads. AAD was less common in residents from residential homes.

CONCLUSIONS: Care home residents, particularly in nursing homes, are frequently prescribed antibiotics and often experience AAD. Antibiotic resistance, including ciprofloxacin resistance, is common in Enterobacteriaceae isolated from the stool of care home residents. Co-amoxiclav is associated with greater risk of AAD than other commonly prescribed antibiotics.

TRIAL REGISTRATION: Current Controlled Trials ISRCTN 7954844.

FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 18, No. 63. See the NIHR Journals Library website for further project information.

Aged, Anti-Bacterial Agents/adverse effects, Clostridium difficile/isolation & purification, Diarrhea/chemically induced, Drug Resistance, Multiple, Bacterial, Feces/microbiology, Female, Homes for the Aged/statistics & numerical data, Humans, Incidence, Male, Nursing Homes/statistics & numerical data, Prospective Studies, Wales
1366-5278
1-84
Hood, Kerenza
af7cf839-ca85-4ea9-83c3-3dd31be88b32
Nuttall, Jacqui
b4c18569-1ab8-4fb6-b72d-1a61ad271a1a
Gillespie, David
a796af31-39b7-47b9-840f-c893e43013dd
Shepherd, Victoria
b0622fcc-79c1-4a83-8457-ec5ae3911bb3
Wood, Fiona
fc0b6a76-2928-4bda-aafc-2be3ac74446b
Duncan, Donna
f23b1ac8-25ff-48ae-9a28-80238a9c1ef8
Stanton, Helen
05e8526c-706a-4615-add9-c942abf8d12a
Espinasse, Aude
ee0917a1-b7d3-4ac4-aac7-497f9b84e428
Wootton, Mandy
4179ab83-aebf-4b01-9203-f067b2bd7d81
Acharjya, Aruna
eefba4a0-f9f5-438f-8b1a-4a0e2e6f7ab9
Allen, Stephen
70bcdcd4-9637-43fe-a907-826a35dcf738
Bayer, Antony
88870477-ad38-4f9b-b304-c2f20dee4987
Carter, Ben
f27540ee-2b8f-43b4-ac06-8bdcafb1ef5f
Cohen, David
8bd9a96d-519b-463a-a69f-8883fd3acbdb
Francis, Nick
9b610883-605c-4fee-871d-defaa86ccf8e
Howe, Robin
e02d3c72-421b-4396-bf99-392e8847247f
Mantzourani, Efi
68471506-55d8-423d-ba21-a9e003032469
Thomas-Jones, Emma
ea15d5ac-8232-4823-ab40-17bec0968520
Toghill, Alun
b8a5fac2-a472-4013-8221-6bc5deae7285
Butler, Christopher C
8bf4cace-c34a-4b65-838f-29c2be91e434
Hood, Kerenza
af7cf839-ca85-4ea9-83c3-3dd31be88b32
Nuttall, Jacqui
b4c18569-1ab8-4fb6-b72d-1a61ad271a1a
Gillespie, David
a796af31-39b7-47b9-840f-c893e43013dd
Shepherd, Victoria
b0622fcc-79c1-4a83-8457-ec5ae3911bb3
Wood, Fiona
fc0b6a76-2928-4bda-aafc-2be3ac74446b
Duncan, Donna
f23b1ac8-25ff-48ae-9a28-80238a9c1ef8
Stanton, Helen
05e8526c-706a-4615-add9-c942abf8d12a
Espinasse, Aude
ee0917a1-b7d3-4ac4-aac7-497f9b84e428
Wootton, Mandy
4179ab83-aebf-4b01-9203-f067b2bd7d81
Acharjya, Aruna
eefba4a0-f9f5-438f-8b1a-4a0e2e6f7ab9
Allen, Stephen
70bcdcd4-9637-43fe-a907-826a35dcf738
Bayer, Antony
88870477-ad38-4f9b-b304-c2f20dee4987
Carter, Ben
f27540ee-2b8f-43b4-ac06-8bdcafb1ef5f
Cohen, David
8bd9a96d-519b-463a-a69f-8883fd3acbdb
Francis, Nick
9b610883-605c-4fee-871d-defaa86ccf8e
Howe, Robin
e02d3c72-421b-4396-bf99-392e8847247f
Mantzourani, Efi
68471506-55d8-423d-ba21-a9e003032469
Thomas-Jones, Emma
ea15d5ac-8232-4823-ab40-17bec0968520
Toghill, Alun
b8a5fac2-a472-4013-8221-6bc5deae7285
Butler, Christopher C
8bf4cace-c34a-4b65-838f-29c2be91e434

Hood, Kerenza, Nuttall, Jacqui, Gillespie, David, Shepherd, Victoria, Wood, Fiona, Duncan, Donna, Stanton, Helen, Espinasse, Aude, Wootton, Mandy, Acharjya, Aruna, Allen, Stephen, Bayer, Antony, Carter, Ben, Cohen, David, Francis, Nick, Howe, Robin, Mantzourani, Efi, Thomas-Jones, Emma, Toghill, Alun and Butler, Christopher C (2014) Probiotics for Antibiotic-Associated Diarrhoea (PAAD): a prospective observational study of antibiotic-associated diarrhoea (including Clostridium difficile-associated diarrhoea) in care homes. Health technology assessment (Winchester, England), 18 (63), 1-84. (doi:10.3310/hta18630).

Record type: Article

Abstract

BACKGROUND: Antibiotic prescribing rates in care homes are higher than in the general population. Antibiotics disrupt the normal gut flora, sometimes causing antibiotic-associated diarrhoea (AAD). Clostridium difficile (Hall and O'Toole 1935) Prévot 1938 is the most commonly identified cause of AAD. Little is known either about the frequency or type of antibiotics prescribed in care homes or about the incidence and aetiology of AAD in this setting.

OBJECTIVES: The Probiotics for Antibiotic-Associated Diarrhoea (PAAD) study was designed as a two-stage study. PAAD stage 1 aimed to (1) prospectively describe antibiotic prescribing in care homes; (2) determine the incidence of C. difficile carriage and AAD (including C. difficile-associated diarrhoea); and (3) to consider implementation challenges and establish the basis for a sample size estimation for a randomised controlled trial (RCT) of probiotic administration with antibiotics to prevent AAD in care homes. If justified by PAAD stage 1, the RCT would be implemented in PAAD stage 2. However, as a result of new evidence regarding the clinical effectiveness of probiotics on the incidence of AAD, a decision was taken not to proceed with PAAD stage 2.

DESIGN: PAAD stage 1 was a prospective observational cohort study in care homes in South Wales with up to 12 months' follow-up for each resident.

SETTING: Recruited care homes had management and owner's agreement to participate and three or more staff willing to take responsibility for implementing the study.

PARTICIPANTS: Eleven care homes were recruited, but one withdrew before any residents were recruited. A total of 279 care home residents were recruited to the observational study and 19 withdrew, 16 (84%) because of moving to a non-participating care home.

MAIN OUTCOME MEASURES: The primary outcomes were the rate of antibiotic prescribing, incidence of AAD, defined as three or more loose stools (type 5-7 on the Bristol Stool Chart) in a 24-hour period, and C. difficile carriage confirmed on stool culture.

RESULTS: Stool samples were obtained at study entry from 81% of participating residents. Over half of the samples contained antibiotic-resistant isolates, with Enterobacteriaceae resistant to ciprofloxacin in 47%. Residents were prescribed an average of 2.16 antibiotic prescriptions per year [95% confidence interval (CI) 1.90 to 2.46]. Antibiotics were less likely to be prescribed to residents from dual-registered homes. The incidence of AAD was 0.57 (95% CI 0.41 to 0.81) episodes per year among those residents who were prescribed antibiotics. AAD was more likely in residents who were prescribed co-amoxiclav than other antibiotics and in those residents who routinely used incontinence pads. AAD was less common in residents from residential homes.

CONCLUSIONS: Care home residents, particularly in nursing homes, are frequently prescribed antibiotics and often experience AAD. Antibiotic resistance, including ciprofloxacin resistance, is common in Enterobacteriaceae isolated from the stool of care home residents. Co-amoxiclav is associated with greater risk of AAD than other commonly prescribed antibiotics.

TRIAL REGISTRATION: Current Controlled Trials ISRCTN 7954844.

FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 18, No. 63. See the NIHR Journals Library website for further project information.

This record has no associated files available for download.

More information

Published date: 1 October 2014
Keywords: Aged, Anti-Bacterial Agents/adverse effects, Clostridium difficile/isolation & purification, Diarrhea/chemically induced, Drug Resistance, Multiple, Bacterial, Feces/microbiology, Female, Homes for the Aged/statistics & numerical data, Humans, Incidence, Male, Nursing Homes/statistics & numerical data, Prospective Studies, Wales

Identifiers

Local EPrints ID: 436495
URI: http://eprints.soton.ac.uk/id/eprint/436495
ISSN: 1366-5278
PURE UUID: ed4fa9a1-44d3-4f3b-a9b2-8e82d0fb8292
ORCID for Nick Francis: ORCID iD orcid.org/0000-0001-8939-7312

Catalogue record

Date deposited: 11 Dec 2019 17:30
Last modified: 17 Mar 2024 03:58

Export record

Altmetrics

Contributors

Author: Kerenza Hood
Author: Jacqui Nuttall
Author: David Gillespie
Author: Victoria Shepherd
Author: Fiona Wood
Author: Donna Duncan
Author: Helen Stanton
Author: Aude Espinasse
Author: Mandy Wootton
Author: Aruna Acharjya
Author: Stephen Allen
Author: Antony Bayer
Author: Ben Carter
Author: David Cohen
Author: Nick Francis ORCID iD
Author: Robin Howe
Author: Efi Mantzourani
Author: Emma Thomas-Jones
Author: Alun Toghill
Author: Christopher C Butler

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×